- Home
- GPCR vs TRMD Comparison
GPCR vs TRMD Comparison
Compare GPCR & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPCR | TRMD |
|---|---|---|
| Founded | 2016 | 1889 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Marine Transportation |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.2B |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GPCR | TRMD |
|---|---|---|
| Price | $49.09 | $31.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $103.17 | $35.00 |
| AVG Volume (30 Days) | ★ 534.2K | 423.5K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 6.61% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.26 | $19.30 |
| 52 Week High | $94.90 | $35.33 |
Technical Indicators
Market Signals| Indicator | GPCR | TRMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 65.70 |
| Support Level | $43.76 | $31.08 |
| Resistance Level | $52.60 | $33.20 |
| Average True Range (ATR) | 2.52 | 0.70 |
| MACD | -0.29 | 0.22 |
| Stochastic Oscillator | 22.33 | 84.91 |
Price Performance
Historical ComparisonAbout GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About TRMD TORM plc
TORM PLC operates as a shipping company mainly owning and operating a fleet of product tankers. It is engaged in the transportation of refined oil products and clean petroleum products, including gasoline, jet fuel, naphtha, and diesel oil. The Company operates through two segments: the Tanker segment and the Marine Engineering segment, deriving the majority of its revenue from the Tanker segment.